Showing results (41-50 of 47) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 47 results.
Rheumatology (Oxford, England)|October 3, 2017
The risk of individual autoantibodies, autoantibody combinations and levels for arthritis development in clinically suspect arthralgiaRobin M Ten Brinck, Hanna W van Steenbergen, Myrthe A M van Delft, et al.
Rheumatology (Oxford, England)|June 29, 2020
Arthritis autoantibodies in individuals without rheumatoid arthritis: follow-up data from a Dutch population-based cohort (Lifelines)Johanna Westra, Elisabeth Brouwer, Elisabeth Raveling-Eelsing, et al.
Rheumatology (Oxford, England)|May 31, 2018
The anti-carbamylated protein antibody response is of overall low avidity despite extensive isotype switchingMyrthe A M van Delft, Marije K Verheul, Leonie E Burgers, et al.
Arthritis Research & Therapy|October 20, 2020
Long-term follow-up of patients with anti-cyclic citrullinated peptide antibody-positive connective tissue disease: a retrospective observational study including information on the HLA-DRB1 allele and citrullination dependencyTakeshi Iwasaki, Shuichiro Nakabo, Chikashi Terao, et al.
Arthritis Research & Therapy|August 17, 2017
The isotype and IgG subclass distribution of anti-carbamylated protein antibodies in rheumatoid arthritis patientsMyrthe A M van Delft, Marije K Verheul, Leonie E Burgers, et al.
Annals of the Rheumatic Diseases|November 29, 2025
Dimerization as a key feature of autoreactive IgA antibody responsesAnouk G van Mourik, Jim B D Keijser, Myrthe A M van Delft, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|May 22, 2018
Triple Positivity for Anti-Citrullinated Protein Autoantibodies, Rheumatoid Factor, and Anti-Carbamylated Protein Antibodies Conferring High Specificity for Rheumatoid Arthritis: Implications for Very Early Identification of At-Risk IndividualsMarije K Verheul, Stefan Böhringer, Myrthe A M van Delft, et al.
Pageof 5